Literature DB >> 17366007

Pertussis seroprevalence in different age groups in Greece.

Ioanna D Pavlopoulou1, Vassiliki Syriopoulou, George L Daikos, Helen Fourlani, Andreas Tzivaras, Dimitrios Petychakis, Maria Theodoridou.   

Abstract

In order to target the appropriate age population for booster vaccination, we examined the antibody titres against pertussis toxin (PT) in different age groups in immunized and non-immunized individuals. In the immunized population, the highest anti-PT levels were observed in the 0- to 2-y age group and the lowest in the teenager and young adult groups. In contrast, in the control group, anti-PT levels were minimal in infants and young children, increasing in adolescence and early adulthood, and waning after 30 y of age. Antibody levels >30 U/ml were observed with higher frequency in children <2 y of age, in individuals with complete vaccination history and in non-immunized individuals. These findings may have important implications in optimizing vaccination policies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366007     DOI: 10.1080/00365540600891299

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

2.  Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.

Authors:  Hans O Hallander; Mikael Andersson; Lennart Gustafsson; Margaretha Ljungman; Eva Netterlid
Journal:  APMIS       Date:  2009-12       Impact factor: 3.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.